BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 8491223)

  • 1. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans.
    Choi Y; Brunken RC; Hawkins RA; Huang SC; Buxton DB; Hoh CK; Phelps ME; Schelbert HR
    Eur J Nucl Med; 1993 Apr; 20(4):308-18. PubMed ID: 8491223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the duration of fasting on myocardial fluorine-18-fluorodeoxyglucose positron emission tomography images in normal males.
    Yamanouchi M; Yoshida K; Niwayama H; Nakagawa K; Aioi S; Shikama N; Himi T; Imazeki K; Itoh Y; Masuda Y
    Jpn Circ J; 1996 Jun; 60(6):319-27. PubMed ID: 8844297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition.
    Tamaki N; Yonekura Y; Kawamoto M; Magata Y; Sasayama S; Takahashi N; Nohara R; Kambara H; Kawai C; Konishi J
    J Nucl Med; 1991 Nov; 32(11):2152-7. PubMed ID: 1941154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography.
    Rechavia E; de Silva R; Kushwaha SS; Rhodes CG; Araujo LI; Jones T; Maseri A; Yacoub MH
    J Am Coll Cardiol; 1997 Aug; 30(2):533-8. PubMed ID: 9247529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
    Spence AM; Muzi M; Graham MM; O'Sullivan F; Krohn KA; Link JM; Lewellen TK; Lewellen B; Freeman SD; Berger MS; Ojemann GA
    J Nucl Med; 1998 Mar; 39(3):440-8. PubMed ID: 9529289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nicotinic acid on exogenous myocardial glucose utilization.
    Stone CK; Holden JE; Stanley W; Perlman SB
    J Nucl Med; 1995 Jun; 36(6):996-1002. PubMed ID: 7769458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography.
    vom Dahl J; Herman WH; Hicks RJ; Ortiz-Alonso FJ; Lee KS; Allman KC; Wolfe ER; Kalff V; Schwaiger M
    Circulation; 1993 Aug; 88(2):395-404. PubMed ID: 8339403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography.
    Hicks RJ; Herman WH; Kalff V; Molina E; Wolfe ER; Hutchins G; Schwaiger M
    J Am Coll Cardiol; 1991 Jul; 18(1):101-11. PubMed ID: 2050912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
    Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
    J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP.
    Kudoh T; Tamaki N; Magata Y; Konishi J; Nohara R; Iwasaki A; Ono S; Ohtake Y; Sugihara H; Sugihara H; Kuze K; Tsujimura Y; Miyazaki T
    J Nucl Med; 1997 Apr; 38(4):548-53. PubMed ID: 9098200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple method to quantify myocardial glucose metabolism from MB ratio in myocardial FDG PET.
    Nishikawa J; Ohtake T; Yokoyama I; Watanabe T; Momose T; Sasaki Y
    Ann Nucl Med; 1996 Aug; 10(3):323-8. PubMed ID: 8883708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy.
    Yamaguchi H; Hasegawa S; Yoshioka J; Uehara T; Hashimoto K; Kusuoka H; Kuzuya T; Hori M; Nishimura T
    Ann Nucl Med; 2000 Feb; 14(1):33-8. PubMed ID: 10770578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans.
    Gropler RJ; Siegel BA; Lee KJ; Moerlein SM; Perry DJ; Bergmann SR; Geltman EM
    J Nucl Med; 1990 Nov; 31(11):1749-56. PubMed ID: 2230987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose.
    Bøtker HE; Böttcher M; Schmitz O; Gee A; Hansen SB; Cold GE; Nielsen TT; Gjedde A
    J Nucl Cardiol; 1997; 4(2 Pt 1):125-32. PubMed ID: 9115064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fundamental limitations of [18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake.
    Hariharan R; Bray M; Ganim R; Doenst T; Goodwin GW; Taegtmeyer H
    Circulation; 1995 May; 91(9):2435-44. PubMed ID: 7729031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between myocardial blood flow and fasting glucose metabolism in ischemic heart disease. Quantitative assessment by nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose positron emission tomography.
    Watanabe T; Okazaki O; Akutsu Y; Yamanaka H; Michihata T; Katagiri T; Harumi K
    Jpn Heart J; 1998 May; 39(3):275-85. PubMed ID: 9711179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver.
    Choi Y; Hawkins RA; Huang SC; Brunken RC; Hoh CK; Messa C; Nitzsche EU; Phelps ME; Schelbert HR
    J Nucl Med; 1994 May; 35(5):818-23. PubMed ID: 8176464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.
    Ohtake T; Yokoyama I; Watanabe T; Momose T; Serezawa T; Nishikawa J; Sasaki Y
    J Nucl Med; 1995 Mar; 36(3):456-63. PubMed ID: 7884509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
    Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U
    Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies.
    Choi Y; Hawkins RA; Huang SC; Gambhir SS; Brunken RC; Phelps ME; Schelbert HR
    J Nucl Med; 1991 Apr; 32(4):733-8. PubMed ID: 2013815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.